A Study of the Immunogenicity, Tolerability, and Safety of a New Formulation of RotaTeq™ in Infants (V260-035)

Clinical trial NCT01600092 · COMPLETED

Trial details

NCT number: NCT01600092
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Rotavirus Gastroenteritis

Start date: 2013-04-29
Primary completion: 2014-03-25
Enrollment: 1020

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.